Literature DB >> 33609356

Is Dry Needling Applied by Physical Therapists Effective for Pain in Musculoskeletal Conditions? A Systematic Review and Meta-Analysis.

Jorge Sánchez-Infante1, Marcos J Navarro-Santana2, Alfredo Bravo-Sánchez1, Fernando Jiménez-Diaz1, Javier Abián-Vicén1.   

Abstract

OBJECTIVE: The main objective of this systematic review and meta-analysis was to determine the short-, medium-, and long-term effectiveness of dry needling (DN) applied by physical therapists to myofascial trigger points for the treatment of pain.
METHODS: PubMed, Scopus, SportDiscus, and Web of Science databases were searched from their inception to February 2020. Randomized controlled trials that compared DN with other treatments or placebo and measured pain with a visual analog Scale or another numerical pain rating scale were included. Two authors used a personalized form to collect the following data relevant to the objectives of the review from each article independently: study design, purpose, sample size, diagnosis, characteristics of DN intervention, characteristics of placebo intervention, outcome measures, period of assessment, body region, DN technique, and number of sessions. The initial search identified 1771 articles. After the selection, 102 articles were assessed for eligibility; 42 of these articles measuring pain were used for the meta-analysis. Four meta-analyses were performed according to the follow-up period from the last reported treatment.
RESULTS: This meta-analysis found a large effect to decrease pain within 72 hours (standardized mean difference [SMD] = -0.81; 95% CI = -1.21 to -0.40), a moderate effect in 1 to 3 weeks (SMD = -0.69; 95% CI = -1.02 to -0.35), a large effect in 4 to 12 weeks (SMD = -0.85; 95% CI = -1.30 to -0.40), and a large effect in 13 to 24 weeks (SMD = -0.81; 95% CI = -1.64 to -0.03). The risk of bias was generally low; however, the heterogeneity of the results downgraded the level of evidence.
CONCLUSIONS: Low-quality evidence that the immediate to 72-hour (large) effect, 4- to 12-week (large) effect, 13- to 24-week (large) effect, and moderate-quality 1- to 3-week (moderate) effect suggested that DN performed by physical therapists was more effective than no treatment, sham DN, and other therapies for reducing pain. IMPACT: DN is commonly used by physical therapists to treat musculoskeletal pain, and it is very important for physical therapists to know the clinical conditions and time periods for which DN is effective in reducing pain in their patients.
© The Author(s) 2021. Published by Oxford University Press on behalf of the American Physical Therapy Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Pain; Physical Therapy; Randomized Controlled Trial; Trigger Points

Mesh:

Year:  2021        PMID: 33609356     DOI: 10.1093/ptj/pzab070

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  3 in total

1.  Acute and Short-Term Effects of Dry Needling in Patients with Chronic Nonspecific Low Back Pain and Hamstring Tightness: A Pilot Study.

Authors:  Mahnaz Bazzaz-Yamchi; Soofia Naghdi; Amin Nakhostin-Ansari; Monavar Hadizadeh; Noureddin Nakhostin Ansari; Ehsan Moghimi; Scott Hasson
Journal:  ScientificWorldJournal       Date:  2021-11-20

2.  A mixed-methods survey of physiotherapists who practice acupuncture and dry needling in Ontario, Canada: practice characteristics, motivations, and professional outcomes.

Authors:  Nadine Ijaz; Sandy Welsh; Heather Boon
Journal:  BMC Complement Med Ther       Date:  2021-10-19

Review 3.  Dry Needling Alone or in Combination with Exercise Therapy versus Other Interventions for Reducing Pain and Disability in Subacromial Pain Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Gonzalo Para-García; Ana María García-Muñoz; José Francisco López-Gil; Juan Diego Ruiz-Cárdenas; Ana Isabel García-Guillén; Francisco Javier López-Román; Silvia Pérez-Piñero; María Salud Abellán-Ruiz; Fernando Cánovas; Desirée Victoria-Montesinos
Journal:  Int J Environ Res Public Health       Date:  2022-09-02       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.